Skip to content
Screener

MaxCyte MXCT Free cash flow

Free cash flow at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$78.1M-18.2%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$923M-16.5%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$46.89M-16.4%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
-$9.86M-462%
GeneDx Holdings logo
GeneDx HoldingsWGS
-$38.86M-1,059%
PDE
Pro-Dex, Inc.PDEX
$1.52M

Other financials

Income statement

See full
Revenue$7.3M-14.5%
Gross profit$5.6M-19.9%
Operating income-$10.2M+28.1%
Net income-$8.9M+28.2%
EPS (diluted)-$0.08+33.3%

Balance sheet

See full
Cash & equivalents$15.0M-1.2%
Total debt$17.3M-6.8%
Total equity$158.8M-16.8%
Total assets$184.7M-16.0%

Cash flow

See full
Operating cash flow-$4.7M+52.7%
CapEx$62.0K-89.4%

Valuation

See full
Market cap$135.2M-9.4%
Enterprise value$137.41M-9.9%
P/S4.4×+0.2×

Profitability

See full
Gross margin79.2%-0.6pp
Operating margin-134.6%-12.2pp
Net margin-114.8%-8.8pp
FCF margin-76.1%-17.1pp

Returns & leverage

See full
Return on equity-20.4%-1.2pp
Debt / equity0.1×0.0×
Current ratio12.3×-0.1×

Where this comes from

Calculated from MaxCyte’s reported figures.

The source filing: MaxCyte’s 10-Q, filed August 13, 2026. Open the filing →

Filed
Aug 13, 2026, 4:32 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-095971

FAQ

What is MaxCyte's free cash flow?
MaxCyte (MXCT) reported free cash flow of -$4.72M in Q2 2026.
How has MaxCyte's free cash flow changed year-over-year?
MaxCyte's free cash flow increased by 54.7% year-over-year, from -$10.44M to -$4.72M.
What is the long-term trend for MaxCyte's free cash flow?
Over 4 years (2021 to 2025), MaxCyte's free cash flow has grown at a 25.7% compound annual growth rate (CAGR), from -$14.51M to -$36.18M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about MaxCyte's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude